• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于吸入的干粉中的颗粒工程。

Particle engineering in dry powders for inhalation.

作者信息

Scherließ Regina, Bock Simon, Bungert Nicholas, Neustock Anna, Valentin Lena

机构信息

Department of Pharmaceutics and Biopharmaceutics, Kiel University, Grasweg 9a, 24118 Kiel, KiNSIS Priority Research Area, Kiel University.

Department of Pharmaceutics and Biopharmaceutics, Kiel University, Grasweg 9a, 24118 Kiel, KiNSIS Priority Research Area, Kiel University.

出版信息

Eur J Pharm Sci. 2022 May 1;172:106158. doi: 10.1016/j.ejps.2022.106158. Epub 2022 Mar 4.

DOI:10.1016/j.ejps.2022.106158
PMID:35248734
Abstract

Drug administration by inhalation is a well-established approach to treat respiratory and systemic diseases. To deliver a drug into the lung dry powder inhalation (DPI) is an advantageous, but yet challenging option. A variety of strategies is available for developing DPI formulations. These formulation strategies should address the present disadvantage of insufficient drug delivery and enable therapies in general or to reach new targets (e.g. mucosal vaccination). To increase therapy safety and efficacy scientists challenge the limits of technical feasibility to engineer respiratory medicines. In this review, we provide a concise overview of particle engineering as enabling formulation technique or as an optimisation approach for existing strategies in pulmonary drug delivery. It comprehensively describes different techniques for particle engineering in carrier-based blends for inhalation. This covers considerations on which attributes are beneficial for carriers, followed by methods to modify such attributes or directly manufacture the desired carriers. Furthermore, this work comprises the current state of knowledge on nanocrystal and nanoparticle production as well as other carrier-free technologies and their applications. This review is completed by a glance in the future of carrier engineering using additive manufacturing.

摘要

吸入给药是治疗呼吸系统疾病和全身性疾病的一种成熟方法。将药物输送到肺部,干粉吸入器(DPI)是一种有利但仍具有挑战性的选择。开发DPI制剂有多种策略。这些制剂策略应解决目前药物递送不足的缺点,并使一般治疗成为可能或实现新的目标(例如粘膜疫苗接种)。为了提高治疗安全性和有效性,科学家们挑战技术可行性的极限来设计呼吸道药物。在本综述中,我们简要概述了颗粒工程,它作为一种使能制剂技术或作为肺部药物递送现有策略的优化方法。它全面描述了用于吸入的基于载体的混合物中颗粒工程的不同技术。这包括对哪些属性对载体有益的考虑,然后是修改这些属性或直接制造所需载体的方法。此外,这项工作包括纳米晶体和纳米颗粒生产以及其他无载体技术及其应用的当前知识状态。通过展望使用增材制造的载体工程的未来,完成了本综述。

相似文献

1
Particle engineering in dry powders for inhalation.用于吸入的干粉中的颗粒工程。
Eur J Pharm Sci. 2022 May 1;172:106158. doi: 10.1016/j.ejps.2022.106158. Epub 2022 Mar 4.
2
Focusing on powder processing in dry powder inhalation product development, manufacturing and performance.专注于干粉吸入制剂研发、生产和性能中的粉末加工。
Int J Pharm. 2022 Feb 25;614:121445. doi: 10.1016/j.ijpharm.2021.121445. Epub 2022 Jan 5.
3
Dry powder inhalation: past, present and future.干粉吸入:过去、现在与未来。
Expert Opin Drug Deliv. 2017 Apr;14(4):499-512. doi: 10.1080/17425247.2016.1224846. Epub 2016 Aug 30.
4
Development of drug alone and carrier-based GLP-1 dry powder inhaler formulations.单独药物和基于载体的 GLP-1 干粉吸入剂制剂的开发。
Int J Pharm. 2022 Apr 5;617:121601. doi: 10.1016/j.ijpharm.2022.121601. Epub 2022 Feb 16.
5
Development of a Carrier Free Dry Powder Inhalation Formulation of Ketotifen for Pulmonary Drug Delivery.用于肺部给药的酮替芬无载体干粉吸入制剂的研发
Drug Res (Stuttg). 2020 Jan;70(1):26-32. doi: 10.1055/a-0649-0814. Epub 2019 Sep 18.
6
Inhalable Nanoparticle-based Dry Powder Formulations for Respiratory Diseases: Challenges and Strategies for Translational Research.可吸入纳米颗粒干粉制剂治疗呼吸系统疾病:转化研究的挑战与策略。
AAPS PharmSciTech. 2023 Apr 4;24(4):98. doi: 10.1208/s12249-023-02559-y.
7
A quantitative approach to predicting lung deposition profiles of pharmaceutical powder aerosols.定量预测药物粉末气溶胶肺部沉积分布的方法。
Int J Pharm. 2021 Jun 1;602:120568. doi: 10.1016/j.ijpharm.2021.120568. Epub 2021 Apr 2.
8
Engineering the right formulation for enhanced drug delivery.工程化合适的制剂以增强药物传递。
Adv Drug Deliv Rev. 2022 Dec;191:114561. doi: 10.1016/j.addr.2022.114561. Epub 2022 Oct 1.
9
Physicochemical stability and aerosolization performance of dry powder inhalation system containing ciprofloxacin hydrochloride.含盐酸环丙沙星的干粉吸入系统的物理化学稳定性和雾化性能。
J Pharm Biomed Anal. 2018 Jan 30;148:73-79. doi: 10.1016/j.jpba.2017.09.019. Epub 2017 Sep 22.
10
Developing Dry Powder Inhaler Formulations.开发干粉吸入制剂。
J Aerosol Med Pulm Drug Deliv. 2024 Apr;37(2):90-99. doi: 10.1089/jamp.2024.29109.davm.

引用本文的文献

1
[Advances in inhalable nano-formulations].[可吸入纳米制剂的进展]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2025 Jul 3;54(4):511-521. doi: 10.3724/zdxbyxb-2024-0650.
2
Impact of Different Hydrate Forms of Magnesium Stearate as a Flow Control Agent on the Physical Stability and Inhalation Efficiency of Carrier-Based Formulations.硬脂酸镁不同水合物形式作为流动控制剂对载体型制剂物理稳定性和吸入效率的影响
Pharmaceutics. 2025 May 28;17(6):711. doi: 10.3390/pharmaceutics17060711.
3
Development of Mannitol-Based Microparticles for Dry Powder Inhalers: Enhancing Pulmonary Delivery of NSAIDs.
用于干粉吸入器的基于甘露醇的微粒的开发:增强非甾体抗炎药的肺部递送。
Pharmaceuticals (Basel). 2025 Jun 19;18(6):923. doi: 10.3390/ph18060923.
4
Nanoparticle-Based Dry Powder Inhaler Containing Ciprofloxacin for Enhanced Targeted Antibacterial Therapy.含环丙沙星的纳米颗粒干粉吸入器用于增强靶向抗菌治疗
Pharmaceutics. 2025 Apr 7;17(4):486. doi: 10.3390/pharmaceutics17040486.
5
Lung-Targeted Itraconazole Delivery Using PVA-Based Nano-in-Microparticles for Improved Treatment of Pulmonary Aspergillosis.使用基于聚乙烯醇的纳米微粒包裹伊曲康唑实现肺部靶向给药以改善肺曲霉病的治疗
Int J Nanomedicine. 2025 Apr 8;20:4357-4380. doi: 10.2147/IJN.S511099. eCollection 2025.
6
Advanced Manufacturing Methods for High-Dose Inhalable Powders.高剂量可吸入粉末的先进制造方法
Pharmaceutics. 2025 Mar 12;17(3):359. doi: 10.3390/pharmaceutics17030359.
7
Particle surface coating for dry powder inhaler formulations.用于干粉吸入剂制剂的颗粒表面包衣
Expert Opin Drug Deliv. 2025 May;22(5):711-727. doi: 10.1080/17425247.2025.2482052. Epub 2025 Mar 26.
8
Determination of 5-fluorouracil anticancer drug solubility in supercritical COusing semi-empirical and machine learning models.使用半经验模型和机器学习模型测定5-氟尿嘧啶抗癌药物在超临界CO₂中的溶解度
Sci Rep. 2025 Feb 7;15(1):4590. doi: 10.1038/s41598-025-87383-z.
9
Solubility of gemcitabine (an anticancer drug) in supercritical carbon dioxide green solvent: Experimental measurement and thermodynamic modeling.吉西他滨(一种抗癌药物)在超临界二氧化碳绿色溶剂中的溶解度:实验测量与热力学建模
Sci Rep. 2025 Feb 6;15(1):4451. doi: 10.1038/s41598-025-88817-4.
10
Cannabidiol and Hydroxypropyl-β-Cyclodextrin for the Development of Deflated Spherical-Shaped Inhalable Powder.用于开发扁球形可吸入粉末的大麻二酚与羟丙基-β-环糊精
AAPS J. 2025 Jan 17;27(1):30. doi: 10.1208/s12248-025-01015-y.